John Morales
- Mental Health
- January 20, 2023
- 13 views
Therapy by AI holds promise and challenges : Shots
Just a year ago, Chukurah Ali had fulfilled a dream of owning her own bakery — Coco’s Desserts in St. Louis, Mo. — which specialized in the sort of custom-made…
- Women'S Health
- January 11, 2023
- 12 views
Postmenopausal hormone therapy and mortality before and after the Women’s Health Initiative study
We observed a diminished systemic HT prevalence and an elevated mortality danger for systemic HT end users in the two study populations in the wake of the 2002 WHI publication…
- Medical Treatment
- December 30, 2022
- 13 views
Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
On-monitor to initiate Phase 2 demo in Q1 2023 NEW YORK, Dec. 29, 2022 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a affected individual-focused biopharmaceutical company, these days announced that the…
- Medical Treatment
- December 21, 2022
- 11 views
Could white light therapy improve fatigue?
Share on PinterestA modest new study indicates light-weight treatment may make improvements to fatigue in many sclerosis. Impression credit history: Cavan Images/Getty Illustrations or photos. A new research from Austria…
- Medical Treatment
- December 4, 2022
- 14 views
Radical new therapy for Parkinson’s will use stem cell transplants | Parkinson’s disease
Early next year, a radical new therapy for Parkinson’s sickness involving tissue transplants will acquire its very first trial with clients – together with a team from the British isles.…
- Medical Treatment
- November 24, 2022
- 12 views
FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B
Washington — U.S. wellness regulators on Tuesday approved the initially gene treatment for hemophilia, a $3.5 million just one-time therapy for the blood-clotting condition. The Food items and Drug Administration cleared…
